Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05306678
What this trial is testing

Breaking Sitting and Metabolic Health in Sedentary Overweight and Obese Adults

Who this might be right for
Metabolic HealthGut HormonesEnergy Balance
National Taiwan Normal University 13
Not applicableWithdrawnNCT01152333
What this trial is testing

The Role of GLP-1 in Satiety Perception in Humans

Who this might be right for
Appetite RegulationObesity
University of Washington
Early research (Phase 1)Study completedNCT00468884
What this trial is testing

Oral Administration of Peptides; Absorption From Gastrointestinal Tract

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 12
Testing effectiveness (Phase 2)Study completedNCT06703021
What this trial is testing

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightChronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 85
Post-approval studies (Phase 4)Not Yet RecruitingNCT07729332
What this trial is testing

Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation

Who this might be right for
Obesity
Massachusetts General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00866658
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 311
Not applicableLooking for participantsNCT07278115
What this trial is testing

Effects on Remission of Type 2 Diabetes Mellitus Following Gastric Bypass Alone vs Gastric Bypass Combined With Truncal Vagotomy

Who this might be right for
Diabetes Mellitus Type 2
University Research Institute for the Study of Genetic & Malignant Disorders in Childhood 40
Not applicableNot Yet RecruitingNCT07605390
What this trial is testing

RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07642635
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Vanderbilt University Medical Center 30
Large-scale testing (Phase 3)Study completedNCT03767543
What this trial is testing

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 265
Not applicableStudy completedNCT03590626
What this trial is testing

Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver DiseaseType2 Diabetes Mellitus
Medanta, The Medicity, India 60
Not applicableLooking for participantsNCT07732426
What this trial is testing

Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

Who this might be right for
Food Addiction TendencyObesityOverweight
Seoul National University Hospital 30
Early research (Phase 1)Study completedNCT04347252
What this trial is testing

Glucagon Regulation of Glucose Metabolism

Who this might be right for
Insulin Secretion
David D'Alessio, M.D. 19
Not applicableUnknownNCT05779644
What this trial is testing

Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus

Who this might be right for
MetforminObesity, AbdominalDiabetes Mellitus, Type 2+4 more
RenJi Hospital 300
Not applicableStudy completedNCT01825148
What this trial is testing

GLP-1 Receptor Targeting in Diabetic and Healthy Individuals

Who this might be right for
Type 1 Diabetes
Radboud University Medical Center 20
Not applicableNot Yet RecruitingNCT06809023
What this trial is testing

Evaluation of Sex Differences in Glucose Metabolism in Response to Sleep Curtailment

Who this might be right for
Sleep DeprivationSex DifferencesGlucose Tolerance
Brigham and Women's Hospital 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT07169942
What this trial is testing

Aleniglipron Phase 2 Body Composition Study

Who this might be right for
Obesity, Overweight, or Chronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07221461
What this trial is testing

Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

Who this might be right for
Wrinkle
Goldman, Butterwick, Fitzpatrick and Groff 24
Testing effectiveness (Phase 2)Ended earlyNCT06515418
What this trial is testing

Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over

Who this might be right for
Obesity
BioAge Labs, Inc. 204
Post-approval studies (Phase 4)Study completedNCT03009916
What this trial is testing

Bileacid Malabsorption and GLP-1 Secretion

Who this might be right for
Bileacid Malabsorption
University Hospital, Gentofte, Copenhagen 24
Next Page